Genetic, clinical underpinnings of subtle early brain change along Alzheimer's dimensions
WEN, J.; Yang, Z.; Nasrallah, I.; Cui, Y.; Erus, G.; Srinivasan, D.; Abdulkadir, A.; Mamourian, E.; Hwang, G.; Singh, A.; Bergman, M.; Bao, J.; Varol, E.; Zhou, Z.; Boquet-Pujadas, A.; Chen, J.; Toga, A. W.; Saykin, A. J.; Hohman, T.; Thompson, P.; Villeneuve, S.; Gollub, R.; Sotiras, A.; Wittfeld, K.; Grabe, H.; Tosun, D.; Bilgel, M.; An, Y.; Marcus, D.; LaMontagne, P. J.; Heckbert, S.; Austin, T.; Launer, L.; Espeland, M.; Masters, C.; Maruff, P.; Fripp, J.; Johnson, S. C.; Morris, j.; Albert, M.; Nick, R.; Resnick, S. M.; Ferrucci, L.; Fan, Y.; Mohamad, H.; Wolk, D.; Shen, L.; Shou, H.; Dav
Show abstract
Alzheimers disease (AD) is associated with heterogeneous atrophy patterns. We employed a semi-supervised clustering technique known as Surreal-GAN, through which we identified two dominant dimensions of brain atrophy in symptomatic mild cognitive impairment (MCI) and AD patients: the "diffuse-AD" (R1) dimension shows widespread brain atrophy, and the "MTL-AD" (R2) dimension displays focal medial temporal lobe (MTL) atrophy. Critically, only R2 was associated with widely known sporadic AD genetic risk factors (e.g., APOE {varepsilon}4) in MCI and AD patients at baseline. We then independently detected the presence of the two dimensions in the early stages by deploying the trained model in the general population and two cognitively unimpaired cohorts of asymptomatic participants. In the general population, genome-wide association studies found 77 genes unrelated to APOE differentially associated with R1 and R2. Functional analyses revealed that these genes were overrepresented in differentially expressed gene sets in organs beyond the brain (R1 and R2), including the heart (R1) and the pituitary gland, muscle, and kidney (R2). These genes were enriched in biological pathways implicated in dendritic cells (R2), macrophage functions (R1), and cancer (R1 and R2). Several of them were "druggable genes" for cancer (R1), inflammation (R1), cardiovascular diseases (R1), and diseases of the nervous system (R2). The longitudinal progression showed that APOE {varepsilon}4, amyloid, and tau were associated with R2 at early asymptomatic stages, but this longitudinal association occurs only at late symptomatic stages in R1. Our findings deepen our understanding of the multifaceted pathogenesis of AD beyond the brain. In early asymptomatic stages, the two dimensions are associated with diverse pathological mechanisms, including cardiovascular diseases, inflammation, and hormonal dysfunction - driven by genes different from APOE - which may collectively contribute to the early pathogenesis of AD.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease 98%
- Individual bioenergetic capacity as a potential source of resilience to Alzheimer’s disease 98%
- DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types 98%
Similar papers in this journal
- Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome 98%
- Tau-first subtype of Alzheimer's disease consistently identified across in vivo and post mortem studies 98%
- Default mode network tau predicts future clinical decline in atypical early Alzheimer’s disease 97%
Similar papers in this journal
- Knockout of the longevity gene Klotho perturbs aging- and Alzheimer's disease-linked brain microRNAs and tRNA fragments 96%
- Improving genetic risk modeling of dementia from real-world data in underrepresented populations 96%
- Detecting the effect of genetic diversity on brain composition in an Alzheimer's disease mouse model 94%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.